Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LFC | Ann: Market Release - Removal from Official List | 24/01/18 | 0 | 620 | |||
|
|||||||
LFC | Ann: Suspension from close of trade today - 17 January 2018 | 17/01/18 | 0 | 512 | |||
|
|||||||
LFC | Ann: Equal Access Share Buy-Back Letter of Offer to Shareholders | 20/12/17 | 0 | 465 | |||
|
|||||||
LFC | Ann: Revised timetable Equal Access Buy Back | 18/12/17 | 0 | 398 | |||
|
|||||||
LFC | Ann: Appendix 3D | 13/12/17 | 0 | 436 | |||
|
|||||||
LFC | Ann: Results of Meeting | 27/11/17 | 0 | 396 | |||
|
|||||||
LFC | News: LFC Life Corporation secures initial funding for Columbarium in principal amount of S$5 mln | 08/11/17 | 0 | 296 | |||
|
|||||||
LFC | Ann: LFC Secures initial Funding for Columbarium | 08/11/17 | 0 | 508 | |||
|
See All Discussions